Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

ML-193

Catalog No. T22103Cas No. 713121-80-3
Alias CID 1261822

ML-193 (CID 1261822) is a potent and selective GPR55 antagonist (IC50: 221 nM) with over 27-fold selectivity for GPR55 over GPR35, CB1, and CB2. It can ameliorate motor and sensorimotor deficits in Parkinson’s disease (PD) rats.

ML-193

ML-193

Purity: 97.74%
Catalog No. T22103Alias CID 1261822Cas No. 713121-80-3
ML-193 (CID 1261822) is a potent and selective GPR55 antagonist (IC50: 221 nM) with over 27-fold selectivity for GPR55 over GPR35, CB1, and CB2. It can ameliorate motor and sensorimotor deficits in Parkinson’s disease (PD) rats.
Pack SizePriceAvailabilityQuantity
5 mg$39In Stock
10 mg$67In Stock
25 mg$112In Stock
50 mg$169In Stock
100 mgInquiryIn Stock
1 mL x 10 mM (in DMSO)$57In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "ML-193"

Select Batch
Purity:97.74%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
ML-193 (CID 1261822) is a potent and selective GPR55 antagonist (IC50: 221 nM) with over 27-fold selectivity for GPR55 over GPR35, CB1, and CB2. It can ameliorate motor and sensorimotor deficits in Parkinson’s disease (PD) rats.
Targets&IC50
GPR55:221 nM
In vitro
ML193, a selective GPR55 antagonist.?ML184 significantly promoted neuronal differentiation in vitro while ML193 reduced differentiation rates as compared to vehicle treatment.Continuous administration of O-1602 into the hippocampus via a cannula connected to an osmotic pump resulted in increased Ki67+ cells within the dentate gyrus.?O-1602 increased immature neuron generation, as assessed by DCX+ and BrdU+ cells, as compared to vehicle-treated animals.?GPR55-/- animals displayed reduced rates of proliferation and neurogenesis within the hippocampus while O-1602 had no effect as compared to vehicle controls[2].
In vivo
Intra-striatal administration of ML193 increased time on the rotarod, decreased latency to remove the label and slip steps in 6-OHDA-lesioned rats mostly at the dose of 1 g/rat[1].
AliasCID 1261822
Chemical Properties
Molecular Weight527.59
FormulaC28H25N5O4S
Cas No.713121-80-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 60 mg/ml (113.72 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8954 mL9.4771 mL18.9541 mL94.7706 mL
5 mM0.3791 mL1.8954 mL3.7908 mL18.9541 mL
10 mM0.1895 mL0.9477 mL1.8954 mL9.4771 mL
20 mM0.0948 mL0.4739 mL0.9477 mL4.7385 mL
50 mM0.0379 mL0.1895 mL0.3791 mL1.8954 mL
100 mM0.0190 mL0.0948 mL0.1895 mL0.9477 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ML-193 | purchase ML-193 | ML-193 cost | order ML-193 | ML-193 chemical structure | ML-193 in vivo | ML-193 in vitro | ML-193 formula | ML-193 molecular weight